- Report
- August 2025
- 187 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 193 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 191 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 182 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 198 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 185 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 188 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 182 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- April 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- April 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- April 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- March 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 185 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- April 2025
- 181 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- September 2025
- 368 Pages
Global
From €5159EUR$5,850USD£4,466GBP

The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression, addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less Read more